FDA approves Amgen's biosimilar to J & J's rheumatoid arthritis drug
The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson& Johnson's blockbuster rheumatoid arthritis drug, Remicade, according to the regulator's website.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | Food and Drug Administration (FDA) | Health | Remicade | Rheumatoid Arthritis | Rheumatology | Websites